The DM project has made substantial progress in several key areas:
• Validation of Raw Material Range for Medical Device Production: The project successfully validated a comprehensive range of raw materials used in the production of medical devices. This validation process included rigorous testing to ensure the materials meet the required standards for safety, durability, and compatibility. This step was critical in confirming the materials' suitability for use in manufacturing medical devices, ensuring they provide consistent quality and performance in medical applications.
• Validation of the Production Line Plan: A thorough validation of the plans for the entire production line was completed, ensuring all proposed components and processes are optimized for efficiency and quality. This involved extensive testing and fine-tuning of the production workflow to guarantee that every aspect of the manufacturing process is well-designed and will operate seamlessly once implemented. The validation ensured that the production line, when built, could consistently produce high-quality medical devices in an efficient and reliable manner. The actual production line has yet to be constructed, pending this validation of the plans.
• Reception of the v2 Deus Light Industrial Production Printer: The project successfully received and integrated the latest version of the Deus Light industrial production printer, version 2. This state-of-the-art printer plays a crucial role in the manufacturing process, offering advanced features and capabilities. The integration of this printer into the production line marks a significant upgrade, enabling higher precision, faster production speeds, and improved overall efficiency. The new printer enhances the project's ability to produce complex and high-quality medical devices on a larger scale.
• Certification ISO 13485 : The project achieved ISO 13485 certification for the production facility, confirming that the facility meets the stringent quality management system requirements for the manufacturing of Class I medical devices (both in-house and subcontracted) and the design of medical devices of all classes. This certification is a critical milestone, ensuring that the production processes adhere to international standards for medical device quality and safety.
• Validation of Biocompatibility: Extensive biocompatibility tests, including cytotoxicity, irritation, and skin sensitization studies, were conducted on Dynasoft25 parts. These tests confirmed that the materials used in manufacturing are safe for medical applications, meeting the requirements of ISO 10993 standards.
• Sterilization Processes: The project successfully validated sterilization methods using ethylene oxide and autoclaving for Dynasoft25 parts. These methods were shown to maintain the mechanical and visual properties of the parts, ensuring they remain effective and safe for use.
• Technological Innovations: The introduction of Dynamic Molding technology has enabled the creation of functional twins and patient-specific medical devices, enhancing surgical planning, training, and in vitro testing capabilities.
